These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7002675)

  • 41. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
    Brown FM; Kamalesh M; Adri MN; Rabinowe SL
    Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden.
    Landin-Olsson M; Karlsson FA; Lernmark A; Sundkvist G
    Diabetes; 1992 Aug; 41(8):1022-7. PubMed ID: 1628762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus.
    Bottazzo GF; Genovese S; Bosi E; Dean BM; Christie MR; Bonifacio E
    Ann Med; 1991 Oct; 23(4):453-61. PubMed ID: 1930942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus.
    Bruining GJ; Molenaar JL; Grobbee DE; Hofman A; Scheffer GJ; Bruining HA; de Bruyn AM; Valkenburg HA
    Lancet; 1989 May; 1(8647):1100-3. PubMed ID: 2566050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
    Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
    Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA-associated heterogeneity of the humoral response to islet antigens in insulin-dependent diabetes.
    Delamaire M; Timsit J; Caillat-Zucman S; Maugendre D; Roussely H; Semana G; Yamamoto AM; van Endert P; Boitard C; Genetet B
    J Autoimmun; 1995 Oct; 8(5):645-57. PubMed ID: 8579721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M
    J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
    Jennings AM; Spencer KM; Dean BM; Wilson RM; Bottazzo GF; Ward JD
    Diabet Med; 1989 Jul; 6(5):434-9. PubMed ID: 2527682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
    Christie MR; Roll U; Payton MA; Hatfield EC; Ziegler AG
    Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
    Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
    Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
    Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
    Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sexual dimorphism in transmission of expression of islet autoantibodies to offspring.
    Yu L; Chase HP; Falorni A; Rewers M; Lernmark A; Eisenbarth GS
    Diabetologia; 1995 Nov; 38(11):1353-7. PubMed ID: 8582546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.
    Kulmala P; Savola K; Petersen JS; Vähäsalo P; Karjalainen J; Löppönen T; Dyrberg T; Akerblom HK; Knip M
    J Clin Invest; 1998 Jan; 101(2):327-36. PubMed ID: 9435304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
    Bingley PJ
    Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients.
    Nicoletti F; Meroni PL; Barcellini W; Steinsväg PO; Di Mauro M; Lunetta M; Pagano M; Consoli U; Zanussi C
    Immunol Lett; 1990 Jan; 23(3):211-5. PubMed ID: 1689697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic alpha cell autoantibodies and glucagon response to arginine.
    Winter WE; Maclaren NK; Riley WJ; Unger RH; Neufeld M; Ozand PT
    Diabetes; 1984 May; 33(5):435-7. PubMed ID: 6373451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.